Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ZLTQ > SEC Filings for ZLTQ > Form 8-K on 3-Dec-2013All Recent SEC Filings

Show all filings for ZELTIQ AESTHETICS INC

Form 8-K for ZELTIQ AESTHETICS INC


3-Dec-2013

Change in Directors or Principal Officers


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 26, 2013, ZELTIQ Aesthetics, Inc. and Kristine Tatsutani, Ph.D., Chief Scientific Officer and Senior Vice President of Clinical, Regulatory and Quality of ZELTIQ, agreed that Dr. Tatsutani would be leaving her position at ZELTIQ and transitioning to a consulting role at ZELTIQ.

On December 3, 2013, ZELTIQ and Dr. Tatsutani entered into a Separation Agreement pursuant to which, until December 31, 2013, Dr. Tatsutani will continue to serve as Chief Scientific Officer of ZELTIQ, to receive her current salary and to be eligible for her annual bonus. Following December 31, 2013, Dr. Tatsutani will:

1. receive severance benefits of six months current salary, and be entitled to have ZELTIQ pay her and her dependents' COBRA premiums for six months or until, if earlier, Dr. Tatsutani becomes eligible for medical coverage through a subsequent employer; and

2. serve as a consultant to ZELTIQ for one year, during which she will receive consulting fees of $12,303 per month and the equity awards she holds will continue to vest.


  Add ZLTQ to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ZLTQ - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.